Literature DB >> 23050789

Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors.

Kiyohiro Hamatani1, Mayumi Mukai, Keiko Takahashi, Yuzo Hayashi, Kei Nakachi, Yoichiro Kusunoki.   

Abstract

BACKGROUND: We previously noted that among atomic bomb survivors (ABS), the relative frequency of cases of adult papillary thyroid cancer (PTC) with chromosomal rearrangements (mainly RET/PTC) was significantly greater in those with relatively higher radiation exposure than those with lower radiation exposure. In contrast, the frequency of PTC cases with point mutations (mainly BRAF(V600E)) was significantly lower in patients with relatively higher radiation exposure than those with lower radiation exposure. We also found that among ABS, the frequency of PTC cases with no detectable gene alterations in RET, neurotrophic tyrosine kinase receptor 1 (NTRK1), BRAF, or RAS was significantly higher in patients with relatively higher radiation exposure than those with lower radiation exposure. However, in ABS with PTC, the relationship between the presence of the anaplastic lymphoma kinase (ALK) gene fused with other gene partners and radiation exposure has received little study. In this study, we tested the hypothesis that the relative frequency of rearranged ALK in ABS with PTC, and with no detectable gene alterations in RET, NTRK1, BRAF, or RAS, would be greater in those having relatively higher radiation exposures.
METHODS: The 105 subjects in the study were drawn from the Life Span Study cohort of ABS of Hiroshima and Nagasaki who were diagnosed with PTC between 1956 and 1993. Seventy-nine were exposed (>0 mGy), and 26 were not exposed to A-bomb radiation. In the 25 ABS with PTC, and with no detectable gene alterations in RET, NTRK1, BRAF, or RAS, we examined archival, formalin-fixed, paraffin-embedded PTC specimens for rearrangement of ALK using reverse transcription-polymerase chain reaction and 5' rapid amplification of cDNA ends (5' RACE).
RESULTS: We found rearranged ALK in 10 of 19 radiation-exposed PTC cases, but none among 6 patients with PTC with no radiation exposure. In addition, solid/trabecular-like architecture in PTC was closely associated with ALK rearrangements, being observed in 6 of 10 PTC cases with ALK rearrangements versus 2 of 15 cases with no ALK rearrangements. The six radiation-exposed cases of PTC harboring both ALK rearrangements and solid/trabecular-like architecture were associated with higher radiation doses and younger ages at the time of the A-bombing and at diagnosis compared to the other 19 PTC with no detectable gene alterations.
CONCLUSION: Our findings suggest that ALK rearrangements are involved in the development of radiation-induced adult-onset PTC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050789      PMCID: PMC3487115          DOI: 10.1089/thy.2011.0511

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  24 in total

Review 1.  Anaplastic lymphoma kinase proteins in growth control and cancer.

Authors:  K Pulford; S W Morris; F Turturro
Journal:  J Cell Physiol       Date:  2004-06       Impact factor: 6.384

Review 2.  Targeting anaplastic lymphoma kinase in lung cancer.

Authors:  Alice T Shaw; Benjamin Solomon
Journal:  Clin Cancer Res       Date:  2011-02-02       Impact factor: 12.531

3.  Improved RT-PCR amplification for molecular analyses with long-term preserved formalin-fixed, paraffin-embedded tissue specimens.

Authors:  Kiyohiro Hamatani; Hidetaka Eguchi; Keiko Takahashi; Kazuaki Koyama; Mayumi Mukai; Reiko Ito; Masataka Taga; Wataru Yasui; Kei Nakachi
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

4.  Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.

Authors:  Misa Imaizumi; Toshiro Usa; Tan Tominaga; Kazuo Neriishi; Masazumi Akahoshi; Eiji Nakashima; Kiyoto Ashizawa; Ayumi Hida; Midori Soda; Saeko Fujiwara; Michiko Yamada; Eri Ejima; Naokata Yokoyama; Masamichi Okubo; Keizo Sugino; Gen Suzuki; Renju Maeda; Shigenobu Nagataki; Katsumi Eguchi
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

5.  The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose.

Authors:  Keiko Takahashi; Hidetaka Eguchi; Koji Arihiro; Reiko Ito; Kojiro Koyama; Midori Soda; John Cologne; Yuzo Hayashi; Yoshihiro Nakata; Kei Nakachi; Kiyohiro Hamatani
Journal:  Mol Carcinog       Date:  2007-03       Impact factor: 4.784

6.  Chernobyl-related thyroid cancer in children of Belarus: a case-control study.

Authors:  L N Astakhova; L R Anspaugh; G W Beebe; A Bouville; V V Drozdovitch; V Garber; Y I Gavrilin; V T Khrouch; A V Kuvshinnikov; Y N Kuzmenkov; V P Minenko; K V Moschik; A S Nalivko; J Robbins; E V Shemiakina; S Shinkarev; S I Tochitskaya; M A Waclawiw
Journal:  Radiat Res       Date:  1998-09       Impact factor: 2.841

7.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

Review 8.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.

Authors:  D E Thompson; K Mabuchi; E Ron; M Soda; M Tokunaga; S Ochikubo; S Sugimoto; T Ikeda; M Terasaki; S Izumi
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

9.  Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.

Authors:  M Shiota; J Fujimoto; M Takenaga; H Satoh; R Ichinohasama; M Abe; M Nakano; T Yamamoto; S Mori
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.

Authors:  Marco Volante; Paola Collini; Yuri E Nikiforov; Atsuhiko Sakamoto; Kennichi Kakudo; Ryohei Katoh; Ricardo V Lloyd; Virginia A LiVolsi; Mauro Papotti; Manuel Sobrinho-Simoes; Gianni Bussolati; Juan Rosai
Journal:  Am J Surg Pathol       Date:  2007-08       Impact factor: 6.394

View more
  21 in total

Review 1.  ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors:  Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

2.  RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.

Authors:  Rebecca J Leeman-Neill; Alina V Brenner; Mark P Little; Tetiana I Bogdanova; Maureen Hatch; Liudmyla Y Zurnadzy; Kiyohiko Mabuchi; Mykola D Tronko; Yuri E Nikiforov
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

3.  Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.

Authors:  Michael J Demeure; Meraj Aziz; Richard Rosenberg; Steven D Gurley; Kimberly J Bussey; John D Carpten
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.

Authors:  David G McFadden; Dora Dias-Santagata; Peter M Sadow; Kerry D Lynch; Carrie Lubitz; Samuel E Donovan; Zongli Zheng; Long Le; A J Iafrate; Gilbert H Daniels
Journal:  J Clin Endocrinol Metab       Date:  2014-08-22       Impact factor: 5.958

5.  Characterization of thyroid cancer driven by known and novel ALK fusions.

Authors:  Federica Panebianco; Alyaksandr V Nikitski; Marina N Nikiforova; Cihan Kaya; Linwah Yip; Vincenzo Condello; Abigail I Wald; Yuri E Nikiforov; Simion I Chiosea
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

6.  N-Acetyl-L-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation.

Authors:  Tomomi Kurashige; Mika Shimamura; Yuji Nagayama
Journal:  Radiat Environ Biophys       Date:  2017-09-04       Impact factor: 1.925

7.  Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.

Authors:  Alyaksandr V Nikitski; Susan L Rominski; Mamta Wankhede; Lindsey M Kelly; Federica Panebianco; Guillermo Barila; Daniel L Altschuler; Yuri E Nikiforov
Journal:  Am J Pathol       Date:  2018-08-18       Impact factor: 4.307

8.  Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.

Authors:  Pierre Vanden Borre; Alexa B Schrock; Peter M Anderson; John C Morris; Andreas M Heilmann; Oliver Holmes; Kai Wang; Adrienne Johnson; Steven G Waguespack; Sai-Hong Ignatius Ou; Saad Khan; Kar-Ming Fung; Philip J Stephens; Rachel L Erlich; Vincent A Miller; Jeffrey S Ross; Siraj M Ali
Journal:  Oncologist       Date:  2017-02-16

Review 9.  Tyrosine kinase gene rearrangements in epithelial malignancies.

Authors:  Alice T Shaw; Peggy P Hsu; Mark M Awad; Jeffrey A Engelman
Journal:  Nat Rev Cancer       Date:  2013-10-17       Impact factor: 60.716

10.  Targeting EML4-ALK gene fusion variant 3 in thyroid cancer.

Authors:  Mehtap Derya Aydemirli; Jaap D H van Eendenburg; Tom van Wezel; Jan Oosting; Willem E Corver; Ellen Kapiteijn; Hans Morreau
Journal:  Endocr Relat Cancer       Date:  2021-05-11       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.